<DOC>
	<DOC>NCT02559037</DOC>
	<brief_summary>The purpose of this study is to observe the efficacy and safety of acupuncture and moxibustion for Crohn's disease and the regulation mechanism of intestinal microbiota and mucosal immunity.</brief_summary>
	<brief_title>Acupuncture and Moxibustion Treatment for Crohn's Disease</brief_title>
	<detailed_description>1. A randomized controlled trial. 2. Acupuncture and moxibustion treatment,placebo control. 3. To observe the efficacy and safety of acupuncture and moxibustion treatment versus placebo controlled for Crohn's disease. 4. To observe the effect on the regulation of intestinal microbiota in Crohn's disease. 5. To observe the effect on the regulation of mucosal immunity in Crohn's disease.</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>1. meet the diagnostic criteria of Crohn's disease; 2. age 1670 3. patients with mild or moderate CD (CDAI between 151 and 360); 4. not taking any medication or taking mesalazine, prednisone (dose â‰¤15mg and have taken at least one month), patients entered the study maintained the same dose unchanged; 5. did not taking immunosuppressive drugs or biological agents such as infliximab within 3 months before entering the study; 6. agreed and signed informed consent. 1. pregnant or lactating patients; 2. associated with heart, brain, liver, kidney and hematopoietic system of serious diseases; 3. mental illness; 4. other serious diseases; 5. the presence of skin disease, fistula, sinus, mutilation and other conditions in the acupoints selected in the study that can not be implemented moxibustion treatment.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>acupuncture</keyword>
	<keyword>moxibustion</keyword>
	<keyword>intestinal microbiota</keyword>
	<keyword>Mucosal immunity</keyword>
</DOC>